Importantly, CYP2C19 loss-of-function alleles are associated with adverse cardiovascular events, including stent thrombosis, stroke, and myocardial infarction caused by reduced responsiveness to the antiplatelet drug clopidogrel [39,40]. The gene discussed is CYP2C19; the disease is stroke disorder.